Want to see HK:1526 full AI Analyst Report?
Rici Healthcare Holdings Ltd. (1526) Ratios
Rici Healthcare Holdings Ltd. Ratios
HK:1526's free cash flow for Q2 2026 was $130.03M. For the 2026 fiscal year, HK:1526's free cash flow was decreased by $-61.64M and operating cash flow was $191.67M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.98 | 0.84 | 0.66 | 0.63 | 0.71 |
| Quick Ratio | 0.96 | 0.81 | 0.65 | 0.60 | 0.68 |
| Cash Ratio | 0.64 | 0.56 | 0.37 | 0.33 | 0.38 |
| Solvency Ratio | 0.23 | 0.13 | 0.22 | 0.12 | 0.09 |
| Operating Cash Flow Ratio | 0.40 | 0.40 | 0.38 | 0.33 | 0.34 |
| Short-Term Operating Cash Flow Coverage | 1.83 | 1.46 | 1.28 | 1.15 | 0.88 |
| Net Current Asset Value | $ -1.41B | $ -1.82B | $ -2.09B | $ -2.31B | $ -2.51B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.41 | 0.47 | 0.49 | 0.50 | 0.60 |
| Debt-to-Equity Ratio | 1.22 | 1.71 | 2.01 | 2.41 | 4.05 |
| Debt-to-Capital Ratio | 0.55 | 0.63 | 0.67 | 0.71 | 0.80 |
| Long-Term Debt-to-Capital Ratio | 0.13 | 0.16 | 0.16 | 0.25 | 0.41 |
| Financial Leverage Ratio | 2.96 | 3.61 | 4.12 | 4.79 | 6.70 |
| Debt Service Coverage Ratio | 1.85 | 1.00 | 1.20 | 0.66 | 0.65 |
| Interest Coverage Ratio | 6.64 | 4.74 | 5.17 | 3.51 | 4.18 |
| Debt to Market Cap | 0.40 | 0.43 | 0.53 | 1.28 | 0.71 |
| Interest Debt Per Share | 1.33 | 1.53 | 1.51 | 1.52 | 1.80 |
| Net Debt to EBITDA | 0.78 | 1.48 | 1.36 | 2.76 | 2.89 |
| Profitability Margins | |||||
| Gross Profit Margin | 43.19% | 39.93% | 41.75% | 39.04% | 41.02% |
| EBIT Margin | 24.31% | 21.41% | 22.48% | 18.19% | 21.90% |
| EBITDA Margin | 39.30% | 27.31% | 35.74% | 24.11% | 28.72% |
| Operating Profit Margin | 23.79% | 20.77% | 21.95% | 18.19% | 21.72% |
| Pretax Profit Margin | 20.29% | 16.55% | 18.23% | 13.78% | 16.49% |
| Net Profit Margin | 10.99% | 10.17% | 12.16% | 12.24% | 7.64% |
| Continuous Operations Profit Margin | 13.70% | 12.13% | 13.43% | 10.24% | 12.35% |
| Net Income Per EBT | 54.13% | 61.44% | 66.68% | 88.88% | 46.31% |
| EBT Per EBIT | 85.30% | 79.66% | 83.06% | 75.75% | 75.93% |
| Return on Assets (ROA) | 6.29% | 6.12% | 7.84% | 6.37% | 4.00% |
| Return on Equity (ROE) | 18.65% | 22.09% | 32.28% | 30.48% | 26.80% |
| Return on Capital Employed (ROCE) | 21.58% | 21.18% | 26.57% | 17.90% | 20.60% |
| Return on Invested Capital (ROIC) | 12.01% | 12.09% | 14.30% | 10.90% | 11.83% |
| Return on Tangible Assets | 6.31% | 6.14% | 7.87% | 6.37% | 4.01% |
| Earnings Yield | 19.20% | 15.92% | 22.15% | 39.82% | 10.38% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.41 | 9.02 | 9.99 | 8.52 | 6.86 |
| Payables Turnover | 10.21 | 10.82 | 10.61 | 8.48 | 7.41 |
| Inventory Turnover | 54.01 | 35.27 | 46.61 | 25.84 | 22.74 |
| Fixed Asset Turnover | 1.00 | 1.05 | 1.09 | 0.89 | 0.86 |
| Asset Turnover | 0.57 | 0.60 | 0.65 | 0.52 | 0.52 |
| Working Capital Turnover Ratio | -15.20 | -5.57 | -3.93 | -3.43 | -3.59 |
| Cash Conversion Cycle | 38.51 | 17.07 | 9.94 | 13.89 | 20.04 |
| Days of Sales Outstanding | 67.49 | 40.45 | 36.52 | 42.83 | 53.24 |
| Days of Inventory Outstanding | 6.76 | 10.35 | 7.83 | 14.13 | 16.05 |
| Days of Payables Outstanding | 35.74 | 33.72 | 34.41 | 43.07 | 49.25 |
| Operating Cycle | 74.25 | 50.79 | 44.35 | 56.96 | 69.29 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.45 | 0.50 | 0.52 | 0.44 | 0.43 |
| Free Cash Flow Per Share | 0.35 | 0.37 | 0.31 | 0.25 | 0.22 |
| Dividend Paid and CapEx Coverage Ratio | 4.56 | 2.81 | 1.60 | 2.28 | 1.91 |
| Capital Expenditure Coverage Ratio | 4.56 | 3.83 | 2.44 | 2.28 | 2.10 |
| Operating Cash Flow Coverage Ratio | 0.36 | 0.34 | 0.36 | 0.31 | 0.25 |
| Operating Cash Flow to Sales Ratio | 0.26 | 0.27 | 0.28 | 0.30 | 0.29 |
| Free Cash Flow Yield | 35.10% | 31.30% | 29.65% | 54.28% | 20.38% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 5.29 | 6.28 | 4.52 | 2.51 | 9.63 |
| Price-to-Sales (P/S) Ratio | 0.57 | 0.64 | 0.55 | 0.31 | 0.74 |
| Price-to-Book (P/B) Ratio | 0.97 | 1.39 | 1.46 | 0.77 | 2.58 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 2.85 | 3.20 | 3.37 | 1.84 | 4.91 |
| Price-to-Operating Cash Flow Ratio | 2.22 | 2.36 | 1.99 | 1.03 | 2.57 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.36 | 0.13 | -0.11 | -0.00 |
| Enterprise Value Multiple | 2.24 | 3.82 | 2.90 | 4.03 | 5.45 |
| Enterprise Value | 2.46B | 3.05B | 3.10B | 2.31B | 3.72B |
| EV to EBITDA | 2.24 | 3.82 | 2.90 | 4.03 | 5.45 |
| EV to Sales | 0.88 | 1.04 | 1.04 | 0.97 | 1.57 |
| EV to Free Cash Flow | 4.38 | 5.22 | 6.36 | 5.83 | 10.44 |
| EV to Operating Cash Flow | 3.42 | 3.86 | 3.75 | 3.27 | 5.46 |
| Tangible Book Value Per Share | 1.07 | 0.85 | 0.69 | 0.57 | 0.36 |
| Shareholders’ Equity Per Share | 1.04 | 0.85 | 0.71 | 0.60 | 0.43 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.32 | 0.27 | 0.26 | 0.26 | 0.25 |
| Revenue Per Share | 1.76 | 1.84 | 1.88 | 1.49 | 1.49 |
| Net Income Per Share | 0.19 | 0.19 | 0.23 | 0.18 | 0.11 |
| Tax Burden | 0.54 | 0.61 | 0.67 | 0.89 | 0.46 |
| Interest Burden | 0.83 | 0.77 | 0.81 | 0.76 | 0.75 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.19 | 0.19 | 0.07 | 0.09 | 0.09 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | -0.00 | 0.00 | 0.01 |
| Income Quality | 1.27 | 1.63 | 2.27 | 2.43 | 3.75 |
Currency in CNY
